Dataset Information

Histopathological and Immunological Findings in the Common Marmoset Following Exposure to Aerosolized SARS-CoV-2

ABSTRACT: There is an enduring requirement to develop animal models of COVID-19 to assess the efficacy of vaccines and therapeutics that can be used to treat the disease in humans. In this study, six marmosets were exposed to a small particle aerosol (1–3 µm) of SARS-CoV-2 VIC01 that delivered the virus directly to the lower respiratory tract. Following the challenge, marmosets did not develop clinical signs, although a disruption to the normal diurnal temperature rhythm was observed in three out of six animals. Early weight loss and changes to respiratory pattern and activity were also observed, yet there was limited evidence of viral replication or lung pathology associated with infection. There was a robust innate immunological response to infection, which included an early increase in circulating neutrophils and monocytes and a reduction in the proportion of circulating T-cells. Expression of the ACE2 receptor in respiratory tissues was almost absent, but there was ubiquitous expression of TMPRSS2. The results of this study indicate that exposure of marmosets to high concentrations of aerosolised SARS-CoV-2 did not result in the development of clear, reproducible signs of COVID-19.

SUBMITTER: Ireland R

PROVIDER: S-EPMC9322862 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Similar Datasets

Project description:COVID-19 is now a pandemic and the knowledge gap on SARS-CoV-2, i.e., the COVID-19 disease agent, dispersion persists. The US Centers for Disease Control and Prevention suggests fomites may not be the main route through which the novel coronavirus spreads. Supporting the same view, the latest the World Health Organization report recommends wearing masks for every individual in public, highlighting the transmission through the air. In the current study AERMOD, one of the most validated and tested models suggested by the USEPA, is used to model SARS-CoV-2-laden PM10 in a hypothetical outdoor environment. Multiple scenarios including particle size, wind speed, source height variations as well as and combined scenarios were modeled to estimated how exposure risk changes with the above-mentioned variables. The results reveal that wind speed majorly narrows infectious plume rather than transferring the peak concentration. The particle size variation indicated that small particles, i.e.,0.01 - 2.5 μm, could reach more than 9 m away from the source in concentration range of 10 - 20 (μg/m 3). On the other hand, source height contributes to peak plume shift rather than dispersing the infected particles. This idea was further studies by using combined scenarios which indicated height difference can impact peak plume displacement rather than wind speed. In the worst-case scenario, the results indicate that the virus-laden particles can travel outdoors more than 8 m away from an infected source. The video output of the model results clearly shows the dynamic of viral peak shifts in several scenarios. The results also indicate that in specific conditions the airborne SARS-CoV-2 can be transported to 9 m away from the source. These findings can be useful for individuals as well as decision-makers to mitigated exposure risk in real-world conditions.Supplementary informationThe online version contains supplementary material available at 10.1007/s40201-020-00602-9.

Dataset Information

Histopathological and Immunological Findings in the Common Marmoset Following Exposure to Aerosolized SARS-CoV-2

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets